drugset / Trial / NCT03961165
BUSCLAB - Buscopan to Prevent Slow Progress in Labor
RandomizedParallel-groupTriple-blindTreatment
Summary
To study the effect of Butylscopolamine Bromide on duration of the active phase of first stage of labor in first time mothers who cross the alert-line for labor dystocia, according to the WHO partograph.
Timeline
- Start
- 2019-05-25
- Primary completion
- 2021-08-29
- Completion
- 2022-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyoscine butylbromide | Unknown | 20 mg | Intravenous |